Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Iron Deficiency Anemia Caused By Malabsorption from Proton Pump Inhibition

Michael Boxer, MD

Blood (2019) 134 (Supplement_1): 962.

https://doi.org/10.1182/blood-2019-122154

Published: 2019

Journal Articles

Improvements in Health-Related Quality of Life and Symptoms in Patients with Previously Untreated Chronic Lymphocytic Leukemia: Final Results from the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine

Alexey Danilov, MD PhD, Habte A Yimer, MD, Michael Boxer, MD, John M Burke, MD, Sunil Babu, MD, Jia Li, PhD, Yong Mun, PhD, Peter C Trask, PhD MPH, Anthony S Masaquel, PhD MPH, Jeff P. Sharman, MD

Blood (2019) 134 (Supplement_1): 3491.

https://doi.org/10.1182/blood-2019-123630

Published: 2019

Journal Articles

Two-Year Safety and Efficacy Outcomes with Fostamatinib in Adult Patients with Immune Thrombocytopenia (ITP): Open-Label Extension to Phase 3 Trial Program

Anne-Marie Duliege, MDMS, Donald M. Arnold, MD MSc, FRCPC, Ralph Boccia, MD, Michael Boxer, MD, Nichola Cooper, MRCP, Quentin A Hill, BSc, MBChB, MRCP, FRCPath, Darla K Liles, MD, Michelle Sholzberg, MDM, MSc, FRCPC, Hany Zayed, PhD, Sandra Tong, MD, James B. Bussel, MD

Blood (2018) 132 (Supplement 1): 736.

https://doi.org/10.1182/blood-2018-99-110482

Published: 2018

Journal Articles

Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia: Initial Results of the Multicenter, Open-Label Extension Period of the Soar Phase 2 Study

David J. Kuter, MD DPhil, Richy Agajanian, MD, Donald M. Arnold, MD MSc, FRCPC, Michael Boxer, MD, Catherine Broome, MD, Joshua J. Field, MD, Irina Murakhovskaya, MD, Kerry A. Rogers, MD, Ann M Lowe, MD, Sandra Tong, MD, Hany Zayed, PhD, Anne-Marie Duliege, MD MS

Blood (2018) 132 (Supplement 1): 3612.

https://doi.org/10.1182/blood-2018-99-110483

Published: 2018

Journal Articles

Improvements in Health-Related Quality of Life and Symptoms in Patients with Previously Untreated Chronic Lymphocytic Leukemia: Results from the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine

Jeffrey P. Sharman, MD, Habte Yimer, MD, Michael Boxer, MD, Nicholas Di Bella, Sunil Babu, Jia Li, PhD, Yong Mun, Peter Trask, Anthony Masaquel, MPH, PhD, Carolina M Reyes, PhD, Alexey Danilov, MD PhD

Blood (2017) 130 (Supplement 1): 683.

https://doi.org/10.1182/blood.V130.Suppl_1.683.683

Published: 2017

Journal Articles

Myeloproliferative Neoplasms and Depressive Symptoms, Diagnosis, and Associations

Leslie Padrnos, MD, Robyn M. Scherber, MD, Blake T. Langlais, Amylou Dueck, PhD, Jennifer Huberty, PhD, Holly L. Geyer, MD, Krisstina L. Gowin, DO, Heidi Kosiorek, MS, Marlene Bruso, MS, Zhenya Senyak, MA, Matthew M Clark, PhD, Michael Boxer, MD, Mary Cotter, MA, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 2161.

https://doi.org/10.1182/blood.V130.Suppl_1.2161.2161

Published: 2017

Journal Articles

Long-Term Maintenance of Platelet Responses in Adult Patients with Persistent/Chronic Immune Thrombocytopenia Treated with Fostamatinib: 1-Year Efficacy and Safety Results

James B. Bussel, MD, Donald M Arnold, MD, Nichola Cooper, MA, MD MRCP, FRCPath, Alhossain A Khalafallah, MD, Michael Boxer, MD, Darla Liles, MD, Waleed Ghanima, MD PhD, Keith McCrae, MD, Hany Zayed, Benoit Cadieux, PhD, Anne-Marie Duliege, MDMS

Blood (2017) 130 (Supplement 1): 16.

https://doi.org/10.1182/blood.V130.Suppl_1.16.16

Published: 2017

Journal Articles

Treating Depression in the Myeloproliferative Neoplasms: The Role and Implications of Poorly Controlled Symptoms and Psychosocial Factors

Robyn M. Scherber, MD MPH, Zhenya Senyak, Heidi E. Kosiorek, MS, Amylou C. Dueck, PhD, Matthew M Clark, PhD, Michael Boxer, MD, Michael A. Goldstein, MD, Mary Cotter, Archie McCallister, Barbara VanHusen, Claire N. Harrison, DM, FRCP, FRCPath, Ruben A. Mesa, MD

Blood (2016) 128 (22): 5474.

https://doi.org/10.1182/blood.V128.22.5474.5474

Published: 2016

Journal Articles

Phase 2 Trial of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)

Jeff P. Sharman, MD, Leonard M. Klein, MD, Michael Boxer, MD, Kathryn S. Kolibaba, MD, Steve Abella, MD, Julie Di Paolo, PhD, Clarence Eng, MPH, Jing Hu, PhD, Jing He, Anita Reddy, PhD, Christopher A. Yasenchak, MD

Blood (2015) 126 (23): 4152.

https://doi.org/10.1182/blood.V126.23.4152.4152

Published: 2015

Journal Articles

Iron Malabsorption Associated with Elevated Serum Gastrin

Michael Boxer, MD

Blood (2015) 126 (23): 3364.

https://doi.org/10.1182/blood.V126.23.3364.3364

Published: 2015

Journal Articles

Phase 2 Trial of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Indolent Non-Hodgkin's Lymphoma (iNHL)

Jeff P. Sharman, MD, Leonard M. Klein, MD, Michael Boxer, MD, Kathryn S. Kolibaba, MD, Steve Abella, MD, Clarence Eng, MPH, Jing He, Jing Hu, PhD, Christopher A. Yasenchak, MD

Blood (2015) 126 (23): 1545.

https://doi.org/10.1182/blood.V126.23.1545.1545

Published: 2015

Journal Articles

High Prevalence of Mood Disorders in MPNs and Their Possible Role in MPN Related Fatigue

Robyn M Scherber, MD MPH, Zhenya Senyak, Amylou Constance Dueck, PhD, Matthew Clark, PhD LP, Michael Boxer, MD, Archie McCallister, MD, Mary Cotter, Barbara VanHusen, Claire N Harrison, DM, FRCP, FRCPath, Ruben Mesa, MD

Blood (2014) 124 (21): 3173.

https://doi.org/10.1182/blood.V124.21.3173.3173

Published: 2014

Journal Articles

Phase 2 Trial of Entospletinib (GS-9973), a Selective SYK Inhibitor, in Follicular Lymphoma (FL)

Jeff P. Sharman, MD, Leonard M. Klein, MD, Michael Boxer, MD, Kathryn S. Kolibaba, MD, Michael J. Hawkins, MD, Steve Abella, MD, Meihua Wu, PhD, Christopher A. Yasenchak, MD

Blood (2014) 124 (21): 4419.

https://doi.org/10.1182/blood.V124.21.4419.4419

Published: 2014

Journal Articles

The Impact of Medical Comorbidities in MPN-Related Fatigue

Robyn M Scherber, MD MPH, Zhenya Senyak, Amylou Constance Dueck, PhD, Matthew Clark, PhD LP, Michael Boxer, MD, Archie McCallister, MD, Mary Cotter, Barbara VanHusen, Claire N. Harrison, DM, FRCP, FRCPath, Ruben Mesa, MD

Blood (2014) 124 (21): 1862.

https://doi.org/10.1182/blood.V124.21.1862.1862

Published: 2014

Journal Articles

Phase 2 Trial Of GS-9973, a Selective Syk Inhibitor, In Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin Lymphoma (NHL)

Jeff P. Sharman, MD, Leonard Klein, MD, Michael Boxer, MD, Kathryn S. Kolibaba, MD, Michael J. Hawkins, MD, Julie A Di Paolo, PhD, Jing Hu, Ph.D, Anita Reddy, PhD, Feng Jin, PhD, Flordeliza Melchor-Khan, BS, Christopher A. Yasenchak, MD

Blood (2013) 122 (21): 1634.

https://doi.org/10.1182/blood.V122.21.1634.1634

Published: 2013

Journal Articles

Myeloproliferative Neoplasm Quality Of Life (MPN-QOL) Study Group: Observational Study Of Quality Of Life and Symptomatic Response In Myelofibrosis Patients Receiving Undergoing Treatment With Conventional Therapy, The Measures Trial and Allogeneic Stem Cell Transplant, The Symptoms Trial

Blood (2013) 122 (21): 4090.

https://doi.org/10.1182/blood.V122.21.4090.4090

Published: 2013

Journal Articles

Consultation for Thrombocytopenia in Hospitalized Patients

Michael Boxer, MD

Blood (2012) 120 (21): 4659.

https://doi.org/10.1182/blood.V120.21.4659.4659

Published: 2012

Journal Articles

Treatments for Marginal Zone Lymphoma.

Michael Boxer, MD, Rashad Aboul Nasr, MD

Blood (2005) 106 (11): 4767.

https://doi.org/10.1182/blood.V106.11.4767.4767

Published: 2005

NARROW

Iron Deficiency Anemia Caused By Malabsorption from Proton Pump Inhibition

Improvements in Health-Related Quality of Life and Symptoms in Patients with Previously Untreated Chronic Lymphocytic Leukemia: Final Results from the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine

Two-Year Safety and Efficacy Outcomes with Fostamatinib in Adult Patients with Immune Thrombocytopenia (ITP): Open-Label Extension to Phase 3 Trial Program

Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia: Initial Results of the Multicenter, Open-Label Extension Period of the Soar Phase 2 Study

Improvements in Health-Related Quality of Life and Symptoms in Patients with Previously Untreated Chronic Lymphocytic Leukemia: Results from the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine

Myeloproliferative Neoplasms and Depressive Symptoms, Diagnosis, and Associations

Long-Term Maintenance of Platelet Responses in Adult Patients with Persistent/Chronic Immune Thrombocytopenia Treated with Fostamatinib: 1-Year Efficacy and Safety Results

Treating Depression in the Myeloproliferative Neoplasms: The Role and Implications of Poorly Controlled Symptoms and Psychosocial Factors

Phase 2 Trial of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)

Iron Malabsorption Associated with Elevated Serum Gastrin

Phase 2 Trial of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Indolent Non-Hodgkin's Lymphoma (iNHL)

High Prevalence of Mood Disorders in MPNs and Their Possible Role in MPN Related Fatigue

Phase 2 Trial of Entospletinib (GS-9973), a Selective SYK Inhibitor, in Follicular Lymphoma (FL)

The Impact of Medical Comorbidities in MPN-Related Fatigue

Phase 2 Trial Of GS-9973, a Selective Syk Inhibitor, In Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin Lymphoma (NHL)

Myeloproliferative Neoplasm Quality Of Life (MPN-QOL) Study Group: Observational Study Of Quality Of Life and Symptomatic Response In Myelofibrosis Patients Receiving Undergoing Treatment With Conventional Therapy, The Measures Trial and Allogeneic Stem Cell Transplant, The Symptoms Trial

Consultation for Thrombocytopenia in Hospitalized Patients

Treatments for Marginal Zone Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only